Endocrinology
Insulin resistance triggers hepatitis C-related liver steatosis and fibrosis
Published in Hepatitis Weekly, August 8th, 2005
"Insulin resistance is a frequent feature of chronic hepatitis C. Whether insulin resistance could be the cause or consequence of steatosis and fibrosis is unknown," researchers in France report.
"The ability of HCV genotype 3 to promote steatosis by itself provides an unique opportunity to answer this question. The aim of the present study was to assess the relationships between insulin resistance, steatosis, and fibrosis according to genotype in 141 non-diabetic patients with biopsy proven non-cirrhotic chronic hepatitis C," wrote L. Fartoux and colleagues, Hopital St....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-08-08)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Occult hepatitis B may hamper interferon in hepatitis C coinfected patients - Hepatitis C Therapy
Short courses of peginterferon clear hepatitis C genotypes 2 or 3 - Rheumatology
Hepatitis C virus infection is not a cause of fibromyalgia - Transplant Medicine
Combination therapy is problematic after hepatitis C-related liver transplants - Allergy & Immunology
Innate immunity overwhelms adenoviral gene expression in the liver - Avian Influenza
International health entity stresses threat from Avian influenza has not ebbed - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
